Sign in
Stories
Mystery of Morning Sickness Unraveled
Share
Empowering Preeclampsia Prevention Campa...
Overview
API
Researchers have uncovered the link between the hormone GDF15 and morning sickness during pregnancy, revealing how lower levels in pregnant women lead to lower sensitivity to the hormone and increase the risk of hyperemesis gravidarum. The international consortium of researchers, including Marlena Fejzo from the University of Southern California, published their findings in Nature, offering potential treatment options for pregnant women affected by hyperemesis gravidarum.
Ask a question
How could this research contribute to the advancement of personalized medicine for pregnant women, allowing for tailored treatment based on individual differences in GDF15 levels?
How might the discovery of the link between GDF15 and morning sickness impact the development of new treatments for pregnant women with hyperemesis gravidarum?
What are the potential implications of this research on the overall understanding of pregnancy-related health issues and their impact on the mother and fetus?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage